QIAGEN sought FDA approval for QIAGEN’s therascreen EGFR RGQ PCR Kit for NSCLC

Read more

Bluegrass Vascular declares enrollment of first patients for SAVE-US Pivotal Trial

Read more

OncoSec Medical proclaims preliminary clinical observations of OMS-1140 Clinical Trial of ImmunoPulse in TNBC patients

Read more

Laminate Medical Technologies rolled out its FDA pivotal trial of the VasQ device

Read more

Box pronounced Box GxP Validation for Life Sciences

Read more

Ligand Pharmaceuticals initiates a program to develop contrast agents for Diagnostic Imaging

Read more

Pandion Therapeutics sought $58 million Series A funding to advance drug programs for autoimmune and inflammatory diseases

Read more

Kite and Pfizer extend Clinical Trial collaboration to assess Yescarta in large B-cell lymphoma

Read more

Avion Pharmaceuticals sought approval of its NDA for Oral Contraceptive Balcoltra

Read more

Relmada Therapeutics obtained global rights to market dextromethadone for treating CNS diseases

Read more